Background: To determine mean prothrombin time and activated partial thromboplastin time in patients of end stage renal disease having normal baseline coagulation parameters after hemodialysis.Methods: In this cross sectional study 84 patients ,16-70 years of age, with end stage renal disease were selected. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) were performed pre and post dialysis on venous blood samples of these patients.Results: Mean predialysis PT and APTT 13.33± 0.96 and 32.45± 1.87 seconds respectively A significant increase in the haemostatic parameters post dialysis was observed with mean PT and APTT 15.64±3.18 and 46.54±24.68 seconds respectively with a p-value of <0.001 for both parameters.Conclu...
Background: Chronic renal failure is a global public health problem; Kidney transplantation and dial...
Coagulation abnormalities in renal pathology are associated with a high thrombotic and hemorrhagic r...
Background: Bleeding at fistula sites in patients with end stage renal disease (ESRD) is a common an...
Background: To determine mean prothrombin time and activated partial thromboplastin time in patients...
Evaluations on Plasma Prothrombin Time (PPT) and Activated Partial Thromboplastin Time (APTT) are re...
An increased bleeding risk is reported for patients with end-stage renal disease. This study aims to...
Renal failure is a situation in which the kidney fails to function adequately. There are two forms o...
Background: Coagulation, also known as blood clotting, is the process by which blood convert from a ...
Abstract. This study was designed to examine the relationship of short activated partial thromboplas...
Clotting time in INTEM (A) corresponds to activated partial thrombin time. Clotting time in INTEM wa...
Introduction: Many laboratories have more than one coagulometer with different types and methods tha...
We measured plasma parameters of the prothrombotic state, namely thrombin-antithrombin III complex (...
We measured plasma parameters of the prothrombotic state, namely thrombin-antithrombin III complex (...
The plasma concentration of prothrombin fragment 1 + 2 (F1 + 2) is considered a very sensitive param...
To assess the blood coagulation function and investigate the appropriate dose of unfractionated hepa...
Background: Chronic renal failure is a global public health problem; Kidney transplantation and dial...
Coagulation abnormalities in renal pathology are associated with a high thrombotic and hemorrhagic r...
Background: Bleeding at fistula sites in patients with end stage renal disease (ESRD) is a common an...
Background: To determine mean prothrombin time and activated partial thromboplastin time in patients...
Evaluations on Plasma Prothrombin Time (PPT) and Activated Partial Thromboplastin Time (APTT) are re...
An increased bleeding risk is reported for patients with end-stage renal disease. This study aims to...
Renal failure is a situation in which the kidney fails to function adequately. There are two forms o...
Background: Coagulation, also known as blood clotting, is the process by which blood convert from a ...
Abstract. This study was designed to examine the relationship of short activated partial thromboplas...
Clotting time in INTEM (A) corresponds to activated partial thrombin time. Clotting time in INTEM wa...
Introduction: Many laboratories have more than one coagulometer with different types and methods tha...
We measured plasma parameters of the prothrombotic state, namely thrombin-antithrombin III complex (...
We measured plasma parameters of the prothrombotic state, namely thrombin-antithrombin III complex (...
The plasma concentration of prothrombin fragment 1 + 2 (F1 + 2) is considered a very sensitive param...
To assess the blood coagulation function and investigate the appropriate dose of unfractionated hepa...
Background: Chronic renal failure is a global public health problem; Kidney transplantation and dial...
Coagulation abnormalities in renal pathology are associated with a high thrombotic and hemorrhagic r...
Background: Bleeding at fistula sites in patients with end stage renal disease (ESRD) is a common an...